CORC

在结果中检索

CORC

浏览/检索结果: 共47条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Carbonate-Induced Chemical Reductants Are Responsible for Iron Acquisition in Strategy I Wild Herbaceous Plants Native to Calcareous Grasslands 期刊论文
PLANT AND CELL PHYSIOLOGY, 2022, 卷号: 63, 期号: 6, 页码: 770-784
作者:  Wang, Baolan;  Wei, Haifang;  Chen, Zhuo;  Li, Yuting;  Zhang, Wen-Hao
收藏  |  浏览/下载：0/0  |  提交时间：2024/03/07
Enhanced accumulation of gibberellins rendered rice seedlings sensitive to ammonium toxicity 期刊论文
JOURNAL OF EXPERIMENTAL BOTANY, 2020, 卷号: 71, 期号: 4, 页码: 1514-1526
作者:  Wang, Baolan;  Wei, Haifang;  Zhang, Hui;  Zhang, Wen-Hao
收藏  |  浏览/下载：25/0  |  提交时间：2022/03/01
Efficacy and safety of IBI305 compared with bevacizumab in advanced non-squamous NSCLC patients as first-line treatment in a randomized, double-blind, phase III study. 会议论文
作者:  Zhang, Li;  Wu, Bin;  Huang, Linian;  Shi, Meiqi;  Liu, Yunpeng
收藏  |  浏览/下载：20/0  |  提交时间：2019/12/05
Efficacy and safety of IBI305 compared with bevacizumab in advanced non-squamous NSCLC patients as first-line treatment in a randomized, double-blind, phase III study. 会议论文
作者:  Zhang, Li;  Wu, Bin;  Huang, Linian;  Shi, Meiqi;  Liu, Yunpeng
收藏  |  浏览/下载：12/0  |  提交时间：2019/12/05
Circulating DNA-Based Sequencing Guided Anlotinib Therapy in Non-Small Cell Lung Cancer 期刊论文
2019, 卷号: 6, 期号: 19, 页码: 1900721
作者:  Lu Jun;  Zhong Hua;  Wu Jun;  Chu Tianqing;  Zhang Lele
收藏  |  浏览/下载：13/0  |  提交时间：2020/01/03
Prognostic factors of refractory NSCLC patients receiving anlotinib hydrochloride as the third- or further-line treatment 期刊论文
CANCER BIOLOGY & MEDICINE, 2018, 卷号: 15, 期号: 4
作者:  Wang, Jing;  Zhao, Yizhuo;  Wang, Qiming;  Zhang, Li;  Shi, Jianhua
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/04
Effect of Anlotinib as a Third-Line or Further Treatment on Overall Survival of Patients With Advanced Non-Small Cell Lung Cancer The ALTER 0303 Phase 3 Randomized Clinical Trial 期刊论文
JAMA ONCOLOGY, 2018, 卷号: 4, 期号: 11
作者:  Han, Baohui;  Li, Kai;  Wang, Qiming;  Zhang, Li;  Shi, Jianhua
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/04
Blood flow in the site of invasive moles within the myometrium after completion of chemotherapy: retrospective study of 33 patients 期刊论文
EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2018, 卷号: 39, 页码: 538-542
作者:  Zhao, Yan;  Gong, Baolan;  Jin, Quanfang;  Wang, Renxiao;  Yue, Yan
收藏  |  浏览/下载：4/0  |  提交时间：2019/11/19
Effect of Anlotinib as a Third-Line or Further Treatment on Overall Survival of Patients With Advanced Non-Small Cell Lung Cancer: The ALTER 0303 Phase 3 Randomized Clinical Trial. 期刊论文
JAMA Oncology, 2018, 卷号: 4, 期号: 11, 页码: 1569-1575
作者:  Han, Baohui*;  Li, Kai*;  Wang, Qiming;  Zhang, Li;  Shi, Jianhua
收藏  |  浏览/下载：7/0  |  提交时间：2019/12/03
Anlotinib as a third-line therapy in patients with refractory advanced non-small-cell lung cancer: a multicentre, randomised phase II trial (ALTER0302) 期刊论文
British Journal of Cancer, 2018, 卷号: 118, 期号: 5, 页码: 654-661
作者:  Han, Baohui*;  Li, Kai;  Zhao, Yizhuo;  Li, Baolan;  Cheng, Ying
收藏  |  浏览/下载：9/0  |  提交时间：2019/12/03

©版权所有 ©2017 CSpace - Powered by CSpace